ENL
ENL
The business
ENL
Small Caps Research
No research on ENL yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise ENL based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Enlitic Takes Ensight Platform Live in US through Intelerad Integration
Enlitic hits US live with Ensight via Intelerad at Radiology Imaging Associates; initial ARR about US$50k as phased rollout begins.
Enlitic joins GE HealthCare in US launch of cloud-enabled Genesis imaging solutions
Artificial intelligence (AI) software specialist Enlitic (ASX: ENL) has welcomed partner GE HealthCare’s launch of a portfolio of unique products in the US. Enlitic is a foundational collaborator in GE HealthCare’s new Genesis portfolio, which the company has designed to facilitate and accelerate the adoption of cloud technologies by healthcare providers. Enlitic’s Ensight Suite is […]
Enlitic and GE HealthCare partner to revolutionise AI-driven medical imaging migration
Data management software developer Enlitic (ASX: ENL) has secured a strategic collaboration with GE HealthCare to revolutionise large-scale artificial intelligence (AI)-driven migrations for medical imaging data. The deal builds on a master services agreement already in place between Enlitic subsidiary Laitek and GE HealthCare. Enlitic anticipates the partnership will help streamline application migrations, enabling healthcare […]
Enlitic expands ENDEX platform market reach with Bayer, Philips agreements
Medical technology developer Enlitic (ASX: ENL) has achieved a double breakthrough with its artificial intelligence-powered ENDEX product for radiation dosimetry. On a milestone day, Enlitic signed separate three-year contracts with Bayer Healthcare and Philips Healthcare related to its ENDEX application. ENDEX transforms new and historical medical image data descriptions into a consistent, clinically-relevant standard nomenclature […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.